Table 2. Phenotype of patient CTL lines... | American Society of Hematology

Table 2.

Phenotype of patient CTL lines for infusion

Patient no.	CD3⁺/TCRαβ⁺, %	CD3⁺/TCRγδ⁺, %	CD3⁺/CD4⁺, %	CD3⁺/CD8⁺, %	CD3⁺/CD56⁺, %	CD3⁺/CD56⁺, %	CD3^-/CD16⁺, %
729	92.3	5.6	5.4	87.8	46.9	3.1	3.4
606	96.4	0.9	1.0	95.1	5.7	2.6	2.7
697	85.9	8.6	17.1	73.2	31.7	5.1	5.2
815	86.1	12.0	3.7	78.7	10.1	1.9	1.6
845	71.7	30.2	4.6	67.2	25.4	0.2	0.0
894	83.8	2.4	11.1	72.9	12.8	13.8	10.4
389	98.0	0.1	0.2	97.0	24.9	0.1	0.1
918	95.7	1.4	4.8	91.7	9.7	0.7	0.6
1042	84.2	15.6	1.4	83.5	22.4	2.8	2.7
1046	92.9	1.4	0.3	94.9	31.7	0.9	0.0

Patient no.	CD3⁺/TCRαβ⁺, %	CD3⁺/TCRγδ⁺, %	CD3⁺/CD4⁺, %	CD3⁺/CD8⁺, %	CD3⁺/CD56⁺, %	CD3⁺/CD56⁺, %	CD3^-/CD16⁺, %
729	92.3	5.6	5.4	87.8	46.9	3.1	3.4
606	96.4	0.9	1.0	95.1	5.7	2.6	2.7
697	85.9	8.6	17.1	73.2	31.7	5.1	5.2
815	86.1	12.0	3.7	78.7	10.1	1.9	1.6
845	71.7	30.2	4.6	67.2	25.4	0.2	0.0
894	83.8	2.4	11.1	72.9	12.8	13.8	10.4
389	98.0	0.1	0.2	97.0	24.9	0.1	0.1
918	95.7	1.4	4.8	91.7	9.7	0.7	0.6
1042	84.2	15.6	1.4	83.5	22.4	2.8	2.7
1046	92.9	1.4	0.3	94.9	31.7	0.9	0.0